Insulet Corp. (PODD)
148.66
+3.53
(+2.43%)
USD |
NASDAQ |
Aug 31, 16:00
148.71
+0.05
(+0.03%)
After-Hours: 20:00
Insulet Cash from Operations (Annual) : 569.30M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 569.30M |
| December 31, 2024 | 430.30M |
| December 31, 2023 | 145.40M |
| December 31, 2022 | 119.00M |
| December 31, 2021 | -68.10M |
| December 31, 2020 | 84.00M |
| December 31, 2019 | 98.40M |
| December 31, 2018 | 35.90M |
| December 31, 2017 | 41.21M |
| December 31, 2016 | 15.91M |
| December 31, 2015 | -12.55M |
| Date | Value |
|---|---|
| December 31, 2014 | 8.92M |
| December 31, 2013 | 3.348M |
| December 31, 2012 | -29.06M |
| December 31, 2011 | -25.45M |
| December 31, 2010 | -35.62M |
| December 31, 2009 | -49.32M |
| December 31, 2008 | -82.61M |
| December 31, 2007 | -50.37M |
| December 31, 2006 | -31.82M |
| December 31, 2005 | -20.32M |
| December 31, 2004 | -13.06M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Abbott Laboratories | 9.566B |
| DexCom, Inc. | 1.441B |
| Boston Scientific Corp. | 4.534B |
| PROCEPT BioRobotics Corp. | -48.98M |
| Globus Medical, Inc. | 753.45M |